Thus, we used a recently designed tumor‐targeted bacteriophage (phage)‐derived particle, named transmorphic phage/AAV, TPA, to deliver a transgene expressing the tumor necrosis factor‐alpha (TNFα) for targeted systemic therapy of medulloblastoma. This evidence concerns the gene PLAT and medulloblastoma.